Recent advances in simultaneous analysis of bisphenol A and its conjugates in human matrices: Exposure biomarker perspectives

Science of the Total Environment

Volumn 572, Issue , 2016, Pages 770-781

  Andra, Syam S ^a   Austin, Christine ^a   Yang, Juan ^b   Patel, Dhavalkumar ^a   Arora, Manish ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b SHENZHEN UNIVERSITY   (China)

Author keywords

Biomarkers of exposure; Bisphenol conjugates; Chromatography; Human biomonitoring; Mass spectrometry

Indexed keywords

CHROMATOGRAPHY; EXTRACTION; MASS SPECTROMETRY; PHASE SEPARATION; PHENOLS;

ADVERSE HEALTH EFFECTS; BISPHENOLS; ENVIRONMENTAL CONTAMINANT; EXTERNAL CONTAMINATION; HUMAN BIOMONITORING; POTENTIAL INTERFERENCES; SIMULTANEOUS EXTRACTIONS; SOLID-PHASE EXTRACTION;

BIOMARKERS;

4,4' ISOPROPYLIDENEDIPHENOL; 4,4' ISOPROPYLIDENEDIPHENOL GLUCORONIDE; 4,4' ISOPROPYLIDENEDIPHENOL SULFATE; AGLYCONE; BIOLOGICAL MARKER; UNCLASSIFIED DRUG; BENZHYDRYL DERIVATIVE; BISPHENOL A GLUCURONIDE; ENDOCRINE DISRUPTOR; GLUCURONIDE; PHENOL DERIVATIVE;

BIOMARKER; BIOMONITORING; CHROMATOGRAPHY; ENDOCRINE DISRUPTOR; MASS SPECTROMETRY; PHENOL; PUBLIC HEALTH;

ANALYTIC METHOD; BIOLOGICAL MONITORING; BLOOD; CHEMICAL ANALYSIS; ELECTROSPRAY; ENVIRONMENTAL EXPOSURE; EXTRACTION; HUMAN; IONIZATION; LIQUID CHROMATOGRAPHY; METABOLITE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; SEPARATION TECHNIQUE; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; URINE; ANALYSIS; CHEMISTRY; PROCEDURES;

BENZHYDRYL COMPOUNDS; BIOMARKERS; CHROMATOGRAPHY, LIQUID; ENDOCRINE DISRUPTORS; ENVIRONMENTAL EXPOSURE; GLUCURONIDES; HUMANS; PHENOLS; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY;

EID: 85028256657     PISSN: 00489697     EISSN: 18791026     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2016.07.062     Document Type: Review

References (130)

1. Amiridou, D., Voutsa, D., Alkylphenols and phthalates in bottled waters. J. Hazard. Mater. 185:1 (2011), 281–286.
2. Andra, S.S., et al. Biomonitoring of human exposures to chlorinated derivatives and structural analogs of bisphenol A. Environ. Int. 85 (2015), 352–379.
3. Arbuckle, T.E., et al. Exposure to free and conjugated forms of bisphenol A and triclosan among pregnant women in the MIREC cohort. Environ. Health Perspect. 123:4 (2015), 277–284.
4. Asimakopoulos, A.G., Thomaidis, N.S., Koupparis, M.A., Recent trends in biomonitoring of bisphenol A, 4-t-octylphenol, and 4-nonylphenol. Toxicol. Lett. 210:2 (2012), 141–154.
5. Battal, D., et al. Development and validation of an LC-MS/MS method for simultaneous quantitative analysis of free and conjugated bisphenol A in human urine. Biomed. Chromatogr. 28:5 (2014), 686–693.
6. Battal, D., et al. Determination of urinary levels of bisphenol A in a Turkish population. Environ. Monit. Assess. 186:12 (2014), 8443–8452.
7. Birnbaum, L.S., et al. Consortium-based science: the NIEHS's multipronged, collaborative approach to assessing the health effects of bisphenol A. Environ. Health Perspect. 120:12 (2012), 1640–1644.
8. Bodin, J., Stene, L.C., Nygaard, U.C., Can exposure to environmental chemicals increase the risk of diabetes type 1 development?., 2015, 2015, 208947.
9. Boucher, J.G., Boudreau, A., Atlas, E., Bisphenol A induces differentiation of human preadipocytes in the absence of glucocorticoid and is inhibited by an estrogen-receptor antagonist. Nutr. Diabetes, 4, 2014, e102.
10. Brede, C., et al. Increased migration levels of bisphenol A from polycarbonate baby bottles after dishwashing, boiling and brushing. Food Addit. Contam. 20:7 (2003), 684–689.
11. Brown, A.K., Wong, C.S., Current trends in environmental analysis of human metabolite conjugates of pharmaceuticals. Trends Environ. Anal. Chem. 5 (2015), 8–17.
12. Bursztyka, J., et al. Biotransformation of genistein and bisphenol A in cell lines used for screening endocrine disruptors. Toxicol. in Vitro 22:6 (2008), 1595–1604.
13. Cabaton, N., et al. Biotransformation of bisphenol F by human and rat liver subcellular fractions. Toxicol. in Vitro 22:7 (2008), 1697–1704.
14. Calafat, A.M., et al. Exposure to bisphenol A and other phenols in neonatal intensive care unit premature infants. Environ. Health Perspect. 117:4 (2009), 639–644.
15. Calafat, A.M., et al. Optimal exposure biomarkers for nonpersistent chemicals in environmental epidemiology. Environ. Health Perspect. 123:7 (2015), A166–A168.
16. Calafat, A.M., et al. Response to “comment on ‘optimal exposure biomarkers for nonpersistent chemicals in environmental epidemiology’”. Environ. Health Perspect. 124:4 (2016), A66–A67.
17. Cao, X.L., Corriveau, J., Migration of bisphenol A from polycarbonate baby and water bottles into water under severe conditions. J. Agric. Food Chem. 56:15 (2008), 6378–6381.
18. Cao, X.L., Corriveau, J., Survey of bisphenol A in bottled water products in Canada. Food Addit. Contam. Part B Surveill. 1:2 (2008), 161–164.
19. Cao, X.L., et al. Levels of bisphenol A in canned liquid infant formula products in Canada and dietary intake estimates. J. Agric. Food Chem. 56:17 (2008), 7919–7924.
20. Cao, X.L., et al. Bisphenol A in baby food products in glass jars with metal lids from Canadian markets. J. Agric. Food Chem. 57:12 (2009), 5345–5351.
21. Cao, X.L., Corriveau, J., Popovic, S., Migration of bisphenol A from can coatings to liquid infant formula during storage at room temperature. J. Food Prot. 72:12 (2009), 2571–2574.
22. Cao, X.L., et al. Background bisphenol A in experimental materials and its implication to low-dose in vitro study. Chemosphere 81:6 (2010), 817–820.
23. Cao, X.L., Corriveau, J., Popovic, S., Bisphenol A in canned food products from Canadian markets. J. Food Prot. 73:6 (2010), 1085–1089.
24. Carwile, J.L., et al. Polycarbonate bottle use and urinary bisphenol A concentrations. Environ. Health Perspect. 117:9 (2009), 1368–1372.
25. Carwile, J.L., et al. Canned soup consumption and urinary bisphenol A: a randomized crossover trial. JAMA 306:20 (2011), 2218–2220.
26. Chen, D., et al. Bisphenol analogues other than BPA: environmental occurrence, human exposure, and toxicity—a review. Environ. Sci. Technol. 50:11 (2016), 5438–5453.
27. Collier, A.C., et al. UDP-glucuronosyltransferase activity, expression and cellular localization in human placenta at term. Biochem. Pharmacol. 63:3 (2002), 409–419.
28. Corbel, T., et al. Bidirectional placental transfer of bisphenol A and its main metabolite, bisphenol A-glucuronide, in the isolated perfused human placenta. Reprod. Toxicol. 47 (2014), 51–58.
29. Coughlin, J.L., Winnik, B., Buckley, B., Measurement of bisphenol A, bisphenol A-D-glucuronide, genistein, and genistein 4′ — D-glucuronide via SPE and HPLC-MS/MS. Anal. Bioanal. Chem. 401:3 (2011), 995–1002.
30. Coughtrie, M.W., et al. The inadequacy of perinatal glucuronidation: immunoblot analysis of the developmental expression of individual UDP-glucuronosyltransferase isoenzymes in rat and human liver microsomes. Mol. Pharmacol. 34:6 (1988), 729–735.
31. Dalhamn, T., Edfors, M.L., Rylander, R., Mouth absorption of various compounds in cigarette smoke. Arch. Environ. Health 16:6 (1968), 831–835.
32. Edmonds, J.S., et al. The reaction of bisphenol A 3,4-quinone with DNA. Biochem. Biophys. Res. Commun. 319:2 (2004), 556–561.
33. Elsby, R., et al. Comparison of the modulatory effects of human and rat liver microsomal metabolism on the estrogenicity of bisphenol A: implications for extrapolation to humans. J. Pharmacol. Exp. Ther. 297:1 (2001), 103–113.
34. Fenichel, P., Chevalier, N., Brucker-Davis, F., Bisphenol A: an endocrine and metabolic disruptor. Ann. Endocrinol. 74:3 (2013), 211–220.
35. Fox, S.D., et al. Quantitation of free and total bisphenol A in human urine using liquid chromatography-tandem mass spectrometry. J. Sep. Sci. 34:11 (2011), 1268–1274.
36. Geens, T., Goeyens, L., Covaci, A., Are potential sources for human exposure to bisphenol-A overlooked?. Int. J. Hyg. Environ. Health 214:5 (2011), 339–347.
37. Geens, T., et al. A review of dietary and non-dietary exposure to bisphenol-A. Food Chem. Toxicol. 50:10 (2012), 3725–3740.
38. Geens, T., et al. Levels of bisphenol-A in thermal paper receipts from Belgium and estimation of human exposure. Sci. Total Environ. 435-436 (2012), 30–33.
39. Gerona, R.R., et al. Bisphenol-A (BPA), BPA glucuronide, and BPA sulfate in midgestation umbilical cord serum in a northern and central California population. Environ. Sci. Technol. 47:21 (2013), 12477–12485.
40. Ginsberg, G., Rice, D.C., Does rapid metabolism ensure negligible risk from bisphenol A?. Environ. Health Perspect. 117:11 (2009), 1639–1643.
41. Gonzalez-Parra, E., et al. Bisphenol A in chronic kidney disease. Int. J. Nephrol., 2013, 2013, 437857.
42. Hauck, Z.Z., et al. Determination of bisphenol A-glucuronide in human urine using ultrahigh-pressure liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass Spectrom. 30:3 (2016), 400–406.
43. Holčapek, M., Kolářová, L., Nobilis, M., High-performance liquid chromatography–tandem mass spectrometry in the identification and determination of phase I and phase II drug metabolites. Anal. Bioanal. Chem. 391:1 (2008), 59–78.
44. Inoue, K., et al. Determination of bisphenol A in human serum by high-performance liquid chromatography with multi-electrode electrochemical detection. J. Chromatogr. B Biomed. Sci. Appl. 749:1 (2000), 17–23.
45. Ishibashi, H., et al. Toxicity to early life stages and an estrogenic effect of a bisphenol A metabolite, 4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene on the medaka (Oryzias latipes). Life Sci. 77:21 (2005), 2643–2655.
46. Jaeg, J.P., et al. Characterization of new bisphenol a metabolites produced by CD1 mice liver microsomes and S9 fractions. J. Agric. Food Chem. 52:15 (2004), 4935–4942.
47. Jiang, H.M., et al. New insights for the risk of bisphenol A: inhibition of UDP-glucuronosyltransferases (UGTs). Chemosphere 93:6 (2013), 1189–1193.
48. Kalogera, E., et al. Androgen glucuronides analysis by liquid chromatography tandem-mass spectrometry: could it raise new perspectives in the diagnostic field of hormone-dependent malignancies?. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 940 (2013), 24–34.
49. Kamel, A., Prakash, C., High performance liquid chromatography/atmospheric pressure ionization/tandem mass spectrometry (HPLC/API/MS/MS) in drug metabolism and toxicology. Curr. Drug Metab. 7:8 (2006), 837–852.
50. Kang, J.H., Kito, K., Kondo, F., Factors influencing the migration of bisphenol A from cans. J. Food Prot. 66:8 (2003), 1444–1447.
51. Kang, J.H., Katayama, Y., Kondo, F., Biodegradation or metabolism of bisphenol A: from microorganisms to mammals. Toxicology 217:2–3 (2006), 81–90.
52. Kaushik, R., Levine, B., LaCourse, W.R., A brief review: HPLC methods to directly detect drug glucuronides in biological matrices (part I). Anal. Chim. Acta 556:2 (2006), 255–266.
53. Ketola, R.A., Hakala, K.S., Direct analysis of glucuronides with liquid chromatography-mass spectrometric techniques and methods. Curr. Drug Metab. 11:7 (2010), 561–582.
54. Kolsek, K., Sollner Dolenc, M., Mavri, J., Computational study of the reactivity of bisphenol A-3,4-quinone with deoxyadenosine and glutathione. Chem. Res. Toxicol. 26:1 (2013), 106–111.
55. Kosarac, I., et al. A novel method for the quantitative determination of free and conjugated bisphenol A in human maternal and umbilical cord blood serum using a two-step solid phase extraction and gas chromatography/tandem mass spectrometry. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 898 (2012), 90–94.
56. Kovacic, P., How safe is bisphenol A? Fundamentals of toxicity: metabolism, electron transfer and oxidative stress. Med. Hypotheses 75:1 (2010), 1–4.
57. Lacroix, M.Z., et al. Simultaneous quantification of bisphenol A and its glucuronide metabolite (BPA-G) in plasma and urine: applicability to toxicokinetic investigations. Talanta 85:4 (2011), 2053–2059.
58. Lee, Y.J., et al. Maternal and fetal exposure to bisphenol A in Korea. Reprod. Toxicol. 25 (2008), 413–419.
59. Levsen, K., et al. Structure elucidation of phase II metabolites by tandem mass spectrometry: an overview. J. Chromatogr. A 1067:1–2 (2005), 55–72.
60. Li, M., et al. Biotransformation of bisphenol AF to its major glucuronide metabolite reduces estrogenic activity. PLoS One, 8(12), 2013, e83170.
61. Liao, C., Kannan, K., Widespread occurrence of bisphenol A in paper and paper products: implications for human exposure. Environ. Sci. Technol. 45:21 (2011), 9372–9379.
62. Liao, C., Kannan, K., Determination of free and conjugated forms of bisphenol A in human urine and serum by liquid chromatography-tandem mass spectrometry. Environ. Sci. Technol. 46:9 (2012), 5003–5009.
63. Lindholst, C., et al. Metabolism of bisphenol A in zebrafish (Danio rerio) and rainbow trout (Oncorhynchus mykiss) in relation to estrogenic response. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 135:2 (2003), 169–177.
64. Loganathan, S.N., Kannan, K., Occurrence of bisphenol a in indoor dust from two locations in the eastern United States and implications for human exposures. Arch. Environ. Contam. Toxicol. 61:1 (2011), 68–73.
65. Matsumoto, J., Yokota, H., Yuasa, A., Developmental increases in rat hepatic microsomal UDP-glucuronosyltransferase activities toward xenoestrogens and decreases during pregnancy. Environ. Health Perspect. 110:2 (2002), 193–196.
66. Matthews, J.B., Twomey, K., Zacharewski, T.R., In vitro and in vivo interactions of bisphenol A and its metabolite, bisphenol A glucuronide, with estrogen receptors alpha and beta. Chem. Res. Toxicol. 14:2 (2001), 149–157.
67. Mattison, D.R., et al. Pharmaco- and toxicokinetics of selected exogenous and endogenous estrogens: a review of the data and identification of knowledge gaps. Crit. Rev. Toxicol. 44:8 (2014), 696–724.
68. Mendonca, K., et al. Bisphenol A concentrations in maternal breast milk and infant urine. Int. Arch. Occup. Environ. Health 87:1 (2014), 13–20.
69. Michalowicz, J., Bisphenol A—sources, toxicity and biotransformation. Environ. Toxicol. Pharmacol. 37:2 (2014), 738–758.
70. Mielke, H., Partosch, F., Gundert-Remy, U., The contribution of dermal exposure to the internal exposure of bisphenol A in man. Toxicol. Lett. 204:2–3 (2011), 190–198.
71. Mileva, G., et al. Bisphenol-A: epigenetic reprogramming and effects on reproduction and behavior. Int. J. Environ. Res. Public Health 11:7 (2014), 7537–7561.
72. Mullangi, R., Bhamidipati, R.K., Srinivas, N.R., Curr. Pharm. Anal. 1 (2005), 251–264.
73. Mustieles, V., et al. Bisphenol A: human exposure and neurobehavior. Neurotoxicology 49 (2015), 174–184.
74. Nachman, R.M., et al. Urinary free bisphenol a and bisphenol A-glucuronide concentrations in newborns. J. Pediatr. 162:4 (2013), 870–872.
75. Nachman, R.M., et al. Early life metabolism of bisphenol A: a systematic review of the literature. Curr. Environ. Health Rep. 1:1 (2014), 90–100.
76. Nachman, R.M., et al. Serial free bisphenol a and bisphenol A glucuronide concentrations in neonates. J. Pediatr. 167:1 (2015), 64–69.
77. Nahar, M.S., et al. Fetal liver bisphenol A concentrations and biotransformation gene expression reveal variable exposure and altered capacity for metabolism in humans. J. Biochem. Mol. Toxicol. 27:2 (2013), 116–123.
78. Nakagawa, Y., Suzuki, T., Metabolism of bisphenol A in isolated rat hepatocytes and oestrogenic activity of a hydroxylated metabolite in MCF-7 human breast cancer cells. Xenobiotica 31:3 (2001), 113–123.
79. Nakamura, S., et al. Ipso substitution of bisphenol A catalyzed by microsomal cytochrome P450 and enhancement of estrogenic activity. Toxicol. Lett. 203:1 (2011), 92–95.
80. Nishikawa, M., et al. Placental transfer of conjugated bisphenol A and subsequent reactivation in the rat fetus. Environ. Health Perspect. 118:9 (2010), 1196–1203.
81. Okuda, K., Takiguchi, M., Yoshihara, S., In vivo estrogenic potential of 4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene, an active metabolite of bisphenol A, in uterus of ovariectomized rat. Toxicol. Lett. 197:1 (2010), 7–11.
82. Okuda, K., et al. Novel pathway of metabolic activation of bisphenol A-related compounds for estrogenic activity. Drug Metab. Dispos. 39:9 (2011), 1696–1703.
83. Oppeneer, S.J., Robien, K., Bisphenol A exposure and associations with obesity among adults: a critical review. Public Health Nutr. 18:10 (2015), 1847–1863.
84. Padmanabhan, V., et al. Maternal bisphenol-A levels at delivery: a looming problem?. J. Perinatol. 28:4 (2008), 258–263.
85. Peretz, J., et al. Bisphenol A and reproductive health: update of experimental and human evidence, 2007–2013. Environ. Health Perspect. 122:8 (2014), 775–786.
86. Pottenger, L.H., et al. The relative bioavailability and metabolism of bisphenol A in rats is dependent upon the route of administration. Toxicol. Sci. 54:1 (2000), 3–18.
87. Pritchett, J.J., Kuester, R.K., Sipes, I.G., Metabolism of bisphenol a in primary cultured hepatocytes from mice, rats, and humans. Drug Metab. Dispos. 30:11 (2002), 1180–1185.
88. Provencher, G., et al. Determination of bisphenol A, triclosan and their metabolites in human urine using isotope-dilution liquid chromatography-tandem mass spectrometry. J. Chromatogr. A 1348 (2014), 97–104.
89. Qiu, S.X., Yang, R.Z., Gross, M.L., Synthesis and liquid chromatography/tandem mass spectrometric characterization of the adducts of bisphenol A o-quinone with glutathione and nucleotide monophosphates. Chem. Res. Toxicol. 17:8 (2004), 1038–1046.
90. Ranciere, F., et al. Bisphenol A and the risk of cardiometabolic disorders: a systematic review with meta-analysis of the epidemiological evidence. Environ. Health, 14, 2015, 46.
91. Rudel, R.A., et al. Phthalates, alkylphenols, pesticides, polybrominated diphenyl ethers, and other endocrine-disrupting compounds in indoor air and dust. Environ. Sci. Technol. 37:20 (2003), 4543–4553.
92. Rutkowska, A., Rachon, D., Bisphenol A (BPA) and its potential role in the pathogenesis of the polycystic ovary syndrome (PCOS). Gynecol. Endocrinol. 30:4 (2014), 260–265.
93. Santhi, V.A., et al. Occurrence of bisphenol A in surface water, drinking water and plasma from Malaysia with exposure assessment from consumption of drinking water. Sci. Total Environ. 427-428 (2012), 332–338.
94. Scheidweiler, K.B., Desrosiers, N.A., Huestis, M.A., Simultaneous quantification of free and glucuronidated cannabinoids in human urine by liquid chromatography tandem mass spectrometry. Clin. Chim. Acta 413:23–24 (2012), 1839–1847.
95. Schmidt, J., et al. Bioactivation of bisphenol A and its analogs (BPF, BPAF, BPZ and DMBPA) in human liver microsomes. Toxicol. in Vitro 27:4 (2013), 1267–1276.
96. Schwartz, A.W., Landrigan, P.J., Bisphenol A in thermal paper receipts: an opportunity for evidence-based prevention. Environ. Health Perspect. 120:1 (2012), A14–A15.
97. Staack, R.F., Hopfgartner, G., New analytical strategies in studying drug metabolism. Anal. Bioanal. Chem. 388:7 (2007), 1365–1380.
98. Stahlhut, R.W., Welshons, W.V., Swan, S.H., Bisphenol A data in NHANES suggest longer than expected half-life, substantial nonfood exposure, or both. Environ. Health Perspect. 117:5 (2009), 784–789.
99. Stahlhut, R.W., et al. Comment on “optimal exposure biomarkers for nonpersistent chemicals in environmental epidemiology”. Environ. Health Perspect., 124(4), 2016, A66.
100. Stein, T.P., et al. Bisphenol A exposure in children with autism spectrum disorders. Autism Res. 8:3 (2015), 272–283.
101. Stowell, C.L., et al. A role for sulfation-desulfation in the uptake of bisphenol a into breast tumor cells. Chem. Biol. 13:8 (2006), 891–897.
102. Strassburg, C.P., et al. Developmental aspects of human hepatic drug glucuronidation in young children and adults. Gut 50:2 (2002), 259–265.
103. Suzuki, T., et al. Environmental fate of bisphenol A and its biological metabolites in river water and their xeno-estrogenic activity. Environ. Sci. Technol. 38:8 (2004), 2389–2396.
104. Takao, Y., et al. Release of bisphenol A from food can lining upon heating. J. Health Sci. 48:4 (2002), 331–334.
105. Taylor, J.A., et al. Similarity of bisphenol A pharmacokinetics in rhesus monkeys and mice: relevance for human exposure. Environ. Health Perspect. 119:4 (2011), 422–430.
106. Teeguarden, J.G., et al. Twenty-four hour human urine and serum profiles of bisphenol a during high-dietary exposure. Toxicol. Sci. 123:1 (2011), 48–57.
107. Trabert, B., et al. Urinary bisphenol A-glucuronide and postmenopausal breast cancer in Poland. Cancer Causes Control 25:12 (2014), 1587–1593.
108. Vaidya, S.V., Kulkarni, H., Association of urinary bisphenol A concentration with allergic asthma: results from the national health and nutrition examination survey 2005–2006. J. Asthma 49:8 (2012), 800–806.
109. Vandenberg, L.N., et al. Biomonitoring studies should be used by regulatory agencies to assess human exposure levels and safety of bisphenol A. Environ. Health Perspect. 118:8 (2010), 1051–1054.
110. Vandenberg, L.N., et al. Human exposures to bisphenol A: mismatches between data and assumptions. Rev. Environ. Health 28:1 (2013), 37–58.
111. Vandenberg, L.N., et al. Should oral gavage be abandoned in toxicity testing of endocrine disruptors?. Environ. Health, 13(1), 2014.
112. Vandenberg, L.N., et al. A round robin approach to the analysis of bisphenol a (BPA) in human blood samples. Environ. Health, 13, 2014.
113. Viñas, R., Goldblum, R.M., Watson, C.S., Rapid estrogenic signaling activities of the modified (chlorinated, sulfonated, and glucuronidated) endocrine disruptor bisphenol A. Endocr. Disruptors, 1(1), 2013, e25411.
114. Volkel, W., et al. Metabolism and kinetics of bisphenol a in humans at low doses following oral administration. Chem. Res. Toxicol. 15:10 (2002), 1281–1287.
115. Volkel, W., Bittner, N., Dekant, W., Quantitation of bisphenol A and bisphenol A glucuronide in biological samples by high performance liquid chromatography-tandem mass spectrometry. Drug Metab. Dispos. 33:11 (2005), 1748–1757.
116. Volkel, W., Kiranoglu, M., Fromme, H., Determination of free and total bisphenol A in human urine to assess daily uptake as a basis for a valid risk assessment. Toxicol. Lett. 179:3 (2008), 155–162.
117. vom Saal, F.S., Welshons, W.V., Evidence that bisphenol A (BPA) can be accurately measured without contamination in human serum and urine, and that BPA causes numerous hazards from multiple routes of exposure. Mol. Cell. Endocrinol. 398:1–2 (2014), 101–113.
118. Vom Saal, F.S., et al. The estrogenic endocrine disrupting chemical bisphenol A (BPA) and obesity. Mol. Cell. Endocrinol. 354:1–2 (2012), 74–84.
119. Waechter, J., et al. Factors affecting the accuracy of bisphenol a and bisphenol a-monoglucuronide estimates in mammalian tissues and urine samples. Toxicol. Mech. Methods 17:1 (2007), 13–24.
120. Wilson, N.K., et al. Aggregate exposures of nine preschool children to persistent organic pollutants at day care and at home. J. Expo. Anal. Environ. Epidemiol. 13:3 (2003), 187–202.
121. Yamaguchi, A., et al. Short-term effects of endocrine-disrupting chemicals on the expression of estrogen-responsive genes in male medaka (Oryzias latipes). Aquat. Toxicol. 72:3 (2005), 239–249.
122. Ye, X., et al. Quantification of urinary conjugates of bisphenol A, 2,5-dichlorophenol, and 2-hydroxy-4-methoxybenzophenone in humans by online solid phase extraction-high performance liquid chromatography-tandem mass spectrometry. Anal. Bioanal. Chem. 383:4 (2005), 638–644.
123. Ye, X., et al. Temporal stability of the conjugated species of bisphenol A, parabens, and other environmental phenols in human urine. J. Expo. Sci. Environ. Epidemiol. 17:6 (2007), 567–572.
124. Ye, X., et al. In-vitro oxidation of bisphenol A: is bisphenol A catechol a suitable biomarker for human exposure to bisphenol A?. Anal. Bioanal. Chem. 399:3 (2011), 1071–1079.
125. Ye, X., et al. Potential external contamination with bisphenol A and other ubiquitous organic environmental chemicals during biomonitoring analysis: an elusive laboratory challenge. Environ. Health Perspect. 121:3 (2013), 283–286.
126. Yoshihara, S., et al. Metabolic activation of bisphenol A by rat liver S9 fraction. Toxicol. Sci. 62:2 (2001), 221–227.
127. Yoshihara, S., et al. Potent estrogenic metabolites of bisphenol A and bisphenol B formed by rat liver S9 fraction: their structures and estrogenic potency. Toxicol. Sci. 78:1 (2004), 50–59.
128. Zalko, D., et al. Biotransformations of bisphenol A in a mammalian model: answers and new questions raised by low-dose metabolic fate studies in pregnant CD1 mice. Environ. Health Perspect. 111:3 (2003), 309–319.
129. Zhang, Z., et al. Urinary bisphenol a concentrations and their implications for human exposure in several Asian countries. Environ. Sci. Technol. 45:16 (2011), 7044–7050.
130. Zimmers, S.M., et al. Determination of free bisphenol A (BPA) concentrations in breast milk of U.S. women using a sensitive LC/MS/MS method. Chemosphere 104 (2014), 237–243.